This contract expires in 339 days (Aug 18, 2027).

Browse related active opportunities

NO SET ASIDE USED.

ROCHE DIAGNOSTICS CORPORATION - MOLECULAR DIAGNOSTIC TESTING

PIID: 75N98026P01356
Signed Date: Aug 18, 2026Effective Date: Aug 19, 2026End Date: Closes in 339 days
Award $
$346K
Vendor
ROCHE DIAGNOSTICS CORPORATION
NAICS
541690
Signed Date
Aug 18, 2026

Key Details

Dollars Obligated
$346,254.87
Base & All Options
$346,254.87
Awarding Sub-Agency
National Institutes of Health
Product Service Code
6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Extent Competed
NOT COMPETED UNDER SAP
Number of Offers
1
Place of Performance
INDIANAPOLIS, IN

Description

MOLECULAR DIAGNOSTIC TESTING

Context & Analysis

On Aug 18, 2026, Department of Health and Human Services obligated $346,254.87 to ROCHE DIAGNOSTICS CORPORATION for molecular diagnostic testing. The award is classified under NAICS 541690 — OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in INDIANAPOLIS, IN. The contract is scheduled through Aug 18, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541690 — related awards are listed below.

Contractor Information

UEI: JDMDFEZBYH36
Location: INDIANAPOLIS, IN

Stay Updated

Get notified about new opportunities matching your interests.

Related